Stock UniverseDerived research view · source repositories remain read-only

Codexis, Inc. (CDXS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.45
Global Rank
3305
Market Cap
91.23M
Latest Close
2.56
RS Composite
53.84% · G#128

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-3.76%
3M
108.13%
6M
51.48%
1Y
9.87%
3Y
15.84%
5Y
-87.51%
10Y
-32.63%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.36M · 30-day average: 1.09M · Max drawdown over stored range: -97.65%

Research Snapshot

Relative Strength vs SPX

RS Composite53.84%
20D RS-1.41%
60D RS92.60%
120D RS42.71%
Global RS Rank128 · 96.18% percentile
Watch+Speculative RS Rank68 · 96.76% percentile
Group ScopeWatch+Speculative
Primary RS Rank21 · 95.41% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank448 / 701
Primary Percentile36.23
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CDXS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue69.056104.754138.5970.14359.34570.387
Revenue Growth (YoY)0.874%51.694%32.3%-49.388%-15.394%18.606%
Gross Profit11.12926.62620.458-1.551-3.206
Operating Income-23.92-22.697-31.714-54.801-58.354
Free Cash Flow-20.212-28.0952.977-57.056-53.715-23.847
Free Cash Flow Per Share-0.34-0.4350.046-0.837-0.732-0.27365679006678756
EPS (Diluted) GAAP-0.404481-0.329559-0.514079-1.11902-0.889221
EPS Growth
EPS Non-GAAP
Gross Margin16.116%25.418%14.762%-2.211%-5.402%86.7333%
Operating Margin-34.639%-21.667%-22.883%-78.128%-98.33%-59.2993%
Profit Margin-34.769%-20.313%-24.238%-108.692%-109.994%-62.4746%
Free Cash Flow Margin-29.269%-26.82%2.148%-81.342%-90.513%-33.8798%
Shares Outstanding (Diluted)59.3664.56865.34468.13173.40887.142
Shares Change (YoY)5.015%8.774%1.202%4.265%7.745%18.709%

SEC Quarterly Fundamentals

No processed quarterly rows for CDXS.